Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 2.18% is 37% below its 5-year average of 3.47%, around the middle of its 5-year range (-16.82%–25.33%).
As of the fiscal period ended Tuesday, June 30, 2026. 210.09% above its 12-month average of -1.98%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 2.18%.
RETURN ON EQUITY (ROE)
2.18%
RETURN ON EQUITY (ROE) AVG TTM
-1.98%
RETURN ON EQUITY (ROE) AVG 3Y
-2.12%
RETURN ON EQUITY (ROE) AVG 5Y
3.47%
RETURN ON EQUITY (ROE) AVG 10Y
-1.05%
RETURN ON EQUITY (ROE) AVG 15Y
-2.85%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+210.09%
CURRENT VS 3Y AVG
+202.79%
CURRENT VS 5Y AVG
-37.18%
CURRENT VS 10Y AVG
+307.36%
CURRENT VS 15Y AVG
+176.49%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+105.19%
vs the sector median at left
Pacira BioSciences, Inc.
Market Cap
$973.93M
Return on Equity (ROE)
2.18%
TTM Avg
-1.98%
3Y Avg
-2.12%
5Y Avg
3.47%
Market Cap
$978.09M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
Return on Equity (ROE)
36.64%
TTM Avg
876.73%
3Y Avg
395.64%
5Y Avg
252.56%
Market Cap
$982.46M
Return on Equity (ROE)
-25.78%
TTM Avg
29.18%
3Y Avg
31.59%
5Y Avg
31.59%
Market Cap
$992.14M
Return on Equity (ROE)
N/A
TTM Avg
151.31%
3Y Avg
46.92%
5Y Avg
11.01%
Market Cap
$953.81M
Return on Equity (ROE)
-15.09%
TTM Avg
46.85%
3Y Avg
62.20%
5Y Avg
62.20%
Market Cap
$952.91M
Return on Equity (ROE)
-96.97%
TTM Avg
-57.21%
3Y Avg
-47.20%
5Y Avg
-49.27%
Market Cap
$996.65M
Return on Equity (ROE)
-32.27%
TTM Avg
-24.43%
3Y Avg
-32.70%
5Y Avg
-40.03%
Market Cap
$998.69M
Return on Equity (ROE)
-63.62%
TTM Avg
-41.08%
3Y Avg
-23.78%
5Y Avg
-22.76%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $973.93M | 2.18% | -1.98% | -2.12% | 3.47% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | 36.64% | 876.73% | 395.64% | 252.56% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | -25.78% | 29.18% | 31.59% | 31.59% |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | N/A | 151.31% | 46.92% | 11.01% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -15.09% | 46.85% | 62.20% | 62.20% |
| Savara Inc. (SVRA)vs › | $952.91M | -96.97% | -57.21% | -47.20% | -49.27% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -32.27% | -24.43% | -32.70% | -40.03% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -63.62% | -41.08% | -23.78% | -22.76% |
| Immatics N.V. (IMTX)vs › | $1.01B | -52.47% | -18.98% | -16.96% | -116.25% |
ROE
2.2%
ROA
1.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 2.18% |
| 2026-03-31 | 0.79% |
| 2025-12-31 | 1.01% |
| 2025-09-30 | 2.95% |
| 2025-06-30 | -16.82% |
| 2025-03-31 | -12.99% |
| 2024-12-31 | -12.79% |
| 2024-09-30 | -12.10% |
| 2024-06-30 | 7.23% |
| 2024-03-31 | 7.90% |
| 2023-12-31 | 4.82% |
| 2023-09-30 | 0.84% |
| 2023-06-30 | -0.57% |
| 2023-03-31 | -1.36% |
| 2022-12-31 | 2.05% |
| 2022-09-30 | 2.71% |
| 2022-06-30 | 5.19% |
| 2022-03-31 | 5.42% |
| 2021-12-31 | 5.75% |
| 2021-09-30 | 8.58% |
| 2021-06-30 | 25.33% |
| 2021-03-31 | 22.70% |
| 2020-12-31 | 23.48% |
| 2020-09-30 | 21.57% |
| 2020-06-30 | -2.60% |
| 2020-03-31 | -0.02% |
| 2019-12-31 | -3.10% |
| 2019-09-30 | 0.62% |
| 2019-06-30 | 2.23% |
| 2019-03-31 | 2.27% |
| 2018-12-31 | -0.15% |
| 2018-09-30 | -1.38% |
| 2018-06-30 | -3.83% |
| 2018-03-31 | -12.00% |
| 2017-12-31 | -15.25% |
| 2017-09-30 | -19.33% |
| 2017-06-30 | -25.19% |
| 2017-03-31 | -19.94% |
| 2016-12-31 | -17.33% |
| 2016-09-30 | -17.03% |
| 2016-06-30 | -4.92% |
| 2016-03-31 | -1.44% |
| 2015-12-31 | 0.85% |
| 2015-09-30 | 4.86% |
| 2015-06-30 | 2.08% |
| 2015-03-31 | -0.53% |
| 2014-12-31 | -8.01% |
| 2014-09-30 | -20.30% |
| 2014-06-30 | -29.23% |
| 2014-03-31 | -146.31% |
| 2013-12-31 | -154.93% |
| 2013-09-30 | -139.05% |
| 2013-06-30 | -117.11% |
| 2013-03-31 | -91.02% |
| 2012-12-31 | -79.39% |
| 2012-09-30 | -63.67% |
| 2012-06-30 | -47.60% |
| 2012-03-31 | -122.03% |
| 2011-12-31 | -89.77% |
| 2011-09-30 | -252.90% |
| 2011-06-30 | -145.99% |
| 2011-03-31 | -101.24% |
